title: p53 codon 271 CGT to CAT mutant fraction does not increase in nasal respiratory and olfactory epithelia of rats exposed to inhaled naphthalene.
abstract: A 2-year rat tumor bioassay testing whole body exposure to naphthalene (NA) vapor found a significant increase in nasal respiratory epithelial adenomas in male rats and in olfactory epithelial neuroblastomas in female rats. To obtain mechanistic insight into NA-induced nasal carcinogenesis, NA dose-response was characterized in nasal epithelium using a tumor-relevant endpoint. Specifically, levels of p53 codon 271 CGT to CAT mutation were measured in nasal respiratory and olfactory epithelium of NA-exposed male and female rats by allele-specific competitive blocker-PCR (ACB-PCR). Male and female, 8-9 week-old F344 rats (5 rats/group) were exposed to 0, 0.1, 1.0, 10, and 30ppm NA vapor for 13 weeks (6h/day, 5 days/week). The geometric mean p53 mutant fraction (MF) levels in nasal epithelium of control treatment groups ranged between 2.05 × 10(-5) and 3.05 × 10(-5). No significant dose-related changes in p53 mutant fraction (MF) were observed in the olfactory or respiratory epithelia of female rats. However, statistically significant treatment-related differences were observed in male respiratory and olfactory epithelium, with the p53 MF in the respiratory epithelium of male rats exposed to 30ppm NA significantly lower than that in controls. Further, a significant trend of decreasing p53 MF with increasing dose was observed in the male respiratory epithelium. Of the tissue types analyzed, respiratory epithelium is the most sensitive to the cytotoxic effects of NA, suggesting cytotoxicity may be responsible for the loss of p53 mutation. Because ACB-PCR has been used successfully to detect the effects of known mutagenic carcinogens, the absence of any significant increases in p53 MF associated with NA exposure adds to the weight of evidence that NA does not operate through a directly mutagenic mode of action.
authors.affiliation: National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA.
authors.forename: Fanxue
authors.initials: F
authors.lastname: Meng
authors.forename: Yiying
authors.initials: Y
authors.lastname: Wang
authors.forename: Meagan B
authors.initials: MB
authors.lastname: Myers
authors.forename: Brian A
authors.initials: BA
authors.lastname: Wong
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Gross
authors.forename: Harvey J
authors.initials: HJ
authors.lastname: Clewell
authors.forename: Darol E
authors.initials: DE
authors.lastname: Dodd
authors.forename: Barbara L
authors.initials: BL
authors.lastname: Parsons
mesh_terms: D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D003062:Codon; D004305:Dose-Response Relationship, Drug; D005260:Female; D016158:Genes, p53; D019570:Inhalation Exposure; D008297:Male; D009154:Mutation; D009281:Naphthalenes / Q000633:toxicity*; D009297:Nasal Mucosa / Q000187:drug effects*; D009831:Olfactory Mucosa / Q000187:drug effects*; D051381:Rats; D011916:Rats, Inbred F344; D012727:Sex Characteristics
chemical_list: D002273:Carcinogens; D003062:Codon; D009281:Naphthalenes; C031721:naphthalene